var data={"title":"Interactive diabetes case 2: Switching from oral agents to insulin in type 2 diabetes","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Interactive diabetes case 2: Switching from oral agents to insulin in type 2 diabetes</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/interactive-diabetes-case-2-switching-from-oral-agents-to-insulin-in-type-2-diabetes/contributors\" class=\"contributor contributor_credentials\">Lloyd Axelrod, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/interactive-diabetes-case-2-switching-from-oral-agents-to-insulin-in-type-2-diabetes/contributors\" class=\"contributor contributor_credentials\">David M Nathan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/interactive-diabetes-case-2-switching-from-oral-agents-to-insulin-in-type-2-diabetes/contributors\" class=\"contributor contributor_credentials\">Jean E Mulder, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/interactive-diabetes-case-2-switching-from-oral-agents-to-insulin-in-type-2-diabetes/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jan 03, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">CASE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A 56-year-old woman is referred to you for management of type 2 diabetes.</p><p>Nine years ago the patient experienced three to four months of polyuria, polydipsia, nocturia, dry mouth, and blurred vision. She had habitually consumed large quantities of orange juice and ginger ale and had increased consumption severalfold when polydipsia appeared. She weighed 188 pounds, was 5' 5&quot; tall, and had a body mass index (BMI) of 31.3 <span class=\"nowrap\">kg/m<sup>2</sup></span>. A random glucose level was 237 <span class=\"nowrap\">mg/dL</span> (13.2 <span class=\"nowrap\">mmol/L)</span> and the glycated hemoglobin (A1C) was 10.7 percent. The patient was treated for diabetes with a no-concentrated sweets, low-fat diet, including substitution of diet beverages and water for juices and sodas, and with <a href=\"topic.htm?path=glipizide-drug-information\" class=\"drug drug_general\">glipizide</a> 5 mg by mouth once daily. Over the next six months, the A1C fell to 7.9 percent, and the patient's symptoms resolved.</p><p>Over the ensuing years, the patient's weight increased to 199 pounds, the BMI increased to 33.1 <span class=\"nowrap\">kg/m<sup>2</sup>,</span> the A1C level rose, and the use of oral agents increased. At the present time she takes <a href=\"topic.htm?path=glipizide-drug-information\" class=\"drug drug_general\">glipizide</a> 10 mg by mouth twice daily and <a href=\"topic.htm?path=metformin-drug-information\" class=\"drug drug_general\">metformin</a> 1000 mg by mouth twice daily. The fasting glucose level is consistently 150 to 160 <span class=\"nowrap\">mg/dL</span> (8.3 to 8.9 <span class=\"nowrap\">mmol/L),</span> and the premeal values are in the 200 to 230 <span class=\"nowrap\">mg/dL</span> (11.1 to 12.8 <span class=\"nowrap\">mmol/L)</span> range. The A1C is now 9.7 percent. She eats three meals daily, follows her diet, and counts carbohydrates. The registered dietitian advises you that the patient is doing all of this reasonably well. You conclude that the patient is a secondary failure on oral agents. How would you manage the patient at this time?</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Add NPH insulin 20 units subcutaneously (SQ) daily at bedtime. (See <a href=\"topic.htm?path=interactive-diabetes-case-2-switching-from-oral-agents-to-insulin-in-type-2-diabetes-a1\" class=\"medical medical_answer\">&quot;Interactive diabetes case 2: Switching from oral agents to insulin in type 2 diabetes - A1&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Add glargine insulin 20 units SQ daily at bedtime. (See <a href=\"topic.htm?path=interactive-diabetes-case-2-switching-from-oral-agents-to-insulin-in-type-2-diabetes-a2\" class=\"medical medical_answer\">&quot;Interactive diabetes case 2: Switching from oral agents to insulin in type 2 diabetes - A2&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Add insulin <span class=\"nowrap\">70/30</span> (a mixture of NPH insulin and <a href=\"topic.htm?path=insulin-regular-drug-information\" class=\"drug drug_general\">regular insulin</a> in a 70:30 ratio) 20 units SQ daily before breakfast. (See <a href=\"topic.htm?path=interactive-diabetes-case-2-switching-from-oral-agents-to-insulin-in-type-2-diabetes-a3\" class=\"medical medical_answer\">&quot;Interactive diabetes case 2: Switching from oral agents to insulin in type 2 diabetes - A3&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Add NPH insulin 20 units SQ daily before breakfast. (See <a href=\"topic.htm?path=interactive-diabetes-case-2-switching-from-oral-agents-to-insulin-in-type-2-diabetes-a4\" class=\"medical medical_answer\">&quot;Interactive diabetes case 2: Switching from oral agents to insulin in type 2 diabetes - A4&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=type-2-diabetes-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Type 2 diabetes (The Basics)&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beyond the Basics topics (see <a href=\"topic.htm?path=diabetes-mellitus-type-2-overview-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Diabetes mellitus type 2: Overview (Beyond the Basics)&quot;</a>)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"topicVersionRevision\">Topic 4107 Version 9.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li><a href=\"#H1\" id=\"outline-link-H1\">CASE</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H2\">INFORMATION FOR PATIENTS</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=interactive-diabetes-case-2-switching-from-oral-agents-to-insulin-in-type-2-diabetes-a1\" class=\"medical medical_answer\">Interactive diabetes case 2: Switching from oral agents to insulin in type 2 diabetes - A1</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=interactive-diabetes-case-2-switching-from-oral-agents-to-insulin-in-type-2-diabetes-a2\" class=\"medical medical_answer\">Interactive diabetes case 2: Switching from oral agents to insulin in type 2 diabetes - A2</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=interactive-diabetes-case-2-switching-from-oral-agents-to-insulin-in-type-2-diabetes-a3\" class=\"medical medical_answer\">Interactive diabetes case 2: Switching from oral agents to insulin in type 2 diabetes - A3</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=interactive-diabetes-case-2-switching-from-oral-agents-to-insulin-in-type-2-diabetes-a4\" class=\"medical medical_answer\">Interactive diabetes case 2: Switching from oral agents to insulin in type 2 diabetes - A4</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diabetes-mellitus-type-2-overview-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Diabetes mellitus type 2: Overview (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=type-2-diabetes-the-basics\" class=\"medical medical_basics\">Patient education: Type 2 diabetes (The Basics)</a></li></ul></div></div>","javascript":null}